Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-23

Clinical Trial Update: Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatment of Levemir®

View source ↗

Summary

An observational study in patients with Type 2 diabetes mellitus treated with intensive insulin detemir (Levemir) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED